Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
The compound creates an opportunity for fat loss
(FDA KPV listing) MOTS-c (obesity / osteoporosis) MOTS-c is listed for obesity and osteoporosistwo indications where approved peptide drugs exist (e.g., GLP-1s for obesity) but where the research-peptide ecosystem is still trying to invent shortcuts
Any competitor subject to WADA-compliant testing should treat TB-500 in any form as a prohibited substance
This batch of BPC-157 + TB-500 Peptide Blend has been third-party laboratory tested and verified for quality and consistency
Through its action of taking care of toxins that otherwise would fall to other antioxidants, glutathione frees up these antioxidants to deal with other toxins
the synergy is plausible and clinically observed, but not yet formally proven
